Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy

por Cerezo, Michaël, Rocchi, Stéphane
Publicado 2020

Novel Therapeutic Targets in Melanoma

por Cerezo, Michaël, Rocchi, Stéphane
Publicado 2023

Targeting BIP to induce Endoplasmic Reticulum stress and cancer cell death

por Cerezo, Michaël, Benhida, Rachid, Rocchi, Stéphane
Publicado 2016

Editorial: Non-genetic adaptive drug resistance in cancer

por Cerezo, Michaël, Sun, Xiaoxiao, Shen, Shensi
Publicado 2022

Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib

por Lehraiki, Abdelali, Cerezo, Michael, Rouaud, Florian, Abbe, Patricia, Allegra, Marilyne, Kluza, Jerome, Marchetti, Philippe, Imbert, Veronique, Cheli, Yann, Bertolotto, Corine, Ballotti, Robert, Rocchi, Stéphane
Publicado 2015

Spatial patterns of the cap-binding complex eIF4F in human melanoma cells

por Tang, Xinpu, Pu, Yi, Peng, Haoning, Li, Kaixiu, Faouzi, Sara, Lu, Tianjian, Pu, Dan, Cerezo, Michael, Xu, Jianguo, Li, Lu, Robert, Caroline, Shen, Shensi
Publicado 2023

E2F1 inhibition mediates cell death of metastatic melanoma

por Rouaud, Florian, Hamouda-Tekaya, Nedra, Cerezo, Michaël, Abbe, Patricia, Zangari, Joséphine, Hofman, Veronique, Ohanna, Mickaël, Mograbi, Baharia, El-Hachem, Najla, Benfodda, Zohra, Lebeau, Alexandre, Tulic, Meri K., Hofman, Paul, Bertolotto, Corine, Passeron, Thierry, Annicotte, Jean-Sébastien, Ballotti, Robert, Rocchi, Stéphane
Publicado 2018